Senti Biosciences
SNTI
SNTI
15 hedge funds and large institutions have $5.84M invested in Senti Biosciences in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
29% less capital invested
Capital invested by funds: $8.27M → $5.84M (-$2.43M)
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$78.5K | |
| 2 | +$67.9K | |
| 3 | +$22.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.01K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.97K |
Top Sellers
| 1 | -$358K | |
| 2 | -$117K | |
| 3 | -$37.5K | |
| 4 |
Two Sigma Investments
New York
|
-$22.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.2K |
